![]() Aspira Women's Health Vermillion develops and commercializesdiagnostic teststhat address unmet needs in gynecologic oncology and womens health. | |||
Founding Date | Founding Date 1993 | Founding Date 1986 | Founding Date N/A |
Type | Type Public | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Austin, US HQ | Locations Sydney, AU HQ | Locations HQ |
Employees | Employees 4310% increase | Employees 373 | Employees N/A |

Prosigna is a test for breast cancer developed by Veracyte to measure recurrence risk.
View company